scispace - formally typeset
G

Guoying Jin

Researcher at Jiangnan University

Publications -  11
Citations -  521

Guoying Jin is an academic researcher from Jiangnan University. The author has contributed to research in topics: Microvesicles & Cancer. The author has an hindex of 7, co-authored 7 publications receiving 248 citations.

Papers
More filters
Journal ArticleDOI

LncRNA-FEZF1-AS1 Promotes Tumor Proliferation and Metastasis in Colorectal Cancer by Regulating PKM2 Signaling.

TL;DR: Mechanistic insights are provided into the regulation of FEZF1-AS1 on both STAT3 signaling and glycolysis by binding PKM2 and increasing its stability by binding and increasing the stability of pyruvate kinase 2.
Journal ArticleDOI

A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer

TL;DR: This study demonstrates that a panel of serum exosomal miRNAs containingmiR-21-5p, miR-1246, mi-1229-5 p and mi-96- 5p could significantly distinguish the chemotherapy-resistant group from advanced colorectal cancer patients.
Journal ArticleDOI

Exosome‐mediated delivery of miR‐204‐5p inhibits tumor growth and chemoresistance

TL;DR: It is confirmed that exosomal miR‐204‐5p could efficiently inhibit cancer cell proliferation, induce apoptosis and increase chemosensitivity by specifically suppressing the target genes of miR •204‐ 5p in human cancer cells.
Journal ArticleDOI

LncRNA-SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR-338-3p.

TL;DR: These studies demonstrate that long noncoding RNA (lncRNA) plays an important role in the occurrence and development of human cancer and promotes cell proliferation through SNHG15/miR‐338‐3p/FOS‐RAB14 axis in CRC.
Journal ArticleDOI

Colorectal Cancer-Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD-L1 Expression in Tumor-Associated Macrophages.

TL;DR: It is suggested that inhibiting the secretion of specific sEV-miRNAs from CRC and targeting PD-L1 in TAMs may serve as novel methods for CRC treatment as well as a sensitization method for anti-PD- L1 therapy in CRC.